FDA approves first treatment for non-cystic fibrosis bronchiectasis First DPP1 inhibitor drug milestone marks a long-awaited breakthrough for NCFB patients.

https://www.drugdiscoverynews.com/fda-approves-first-treatment-for-non-cystic-fibrosis-bronchiectasis-16571?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-9huX5GJ5dXrscTFQ29NzSj3wqfq3zTekUu-wVCeT9VRfvY-c6H9SVh_idDNM2WMsfloIvZwqjDhZ_qXZkY5_hd_WCo-w&_hsmi=387404680&utm_content=387404680&utm_source=hs_email